A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2B

This study has been withdrawn prior to enrollment.
(Sponsor decided not to go forward with the study.)
Sponsor:
Information provided by:
Archemix Corp.
ClinicalTrials.gov Identifier:
NCT00694785
First received: June 6, 2008
Last updated: August 20, 2009
Last verified: August 2009
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)